1-4 of 4
Daniele Giovanni Mattei, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combination of AXL Inhibitor Bemcentinib and Low Dose Cytarabine Is Well Tolerated and Efficacious in Elderly Relapsed AML Patients: Update from the Ongoing BGBC003 Phase II Trial (NCT02488408)

Sonja Loges, MD PhD, Michael Heuser, Jörg Chromik, MD, Carlos Enrique Vigil, MD, Peter Paschka, MD, Francesca Re, MD, Nicola Di Renzo, MD, Roberto M. Lemoli, Daniele Giovanni Mattei, MD, Isabel Ben-Batalla, PhD, Monica Hellesoy, PhD, Katherine Lorens, MD, Joseph Birkett, PhD, Stuart McPherson, BSc, Jaya Nautiyal, PhD, David Micklem, PhD, Hani Gabra, MD PhD FRCPE, FRCP, James B. Lorens, PhD, Walter Fiedler, MD, Yesid Alvarado, MD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14.
https://doi.org/10.1182/blood-2020-136566
Published: 2020
Journal Articles

Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06

Chiara Caprioli, MD, Federico Lussana, MD, Silvia Salmoiraghi, BioSc, Roberta Cavagna, BioSc, Ksenija Buklijas, BioSc, Lara Elidi, BioSc, Pamela Zanghì, BioSc, Anna Michelato, PhD, Federica Delaini, MSc, Elena Oldani, MSc, Dario Ferrero, MD, Ernesta Audisio, MD, Filippo Marmont, MD, Elisabetta Terruzzi, MD, Lorella De Paoli, MD, Chiara Cattaneo, MD, Erika Borlenghi, MD, Irene Cavattoni, MD, Monica Tajana, MD, Anna Maria Scattolin, MD, Daniele Giovanni Mattei, MD, Paolo Corradini, Leonardo Campiotti, MD, Fabio Ciceri, MD, Massimo Bernardi, MD, Elisabetta Todisco, MD PhD, Agostino Cortelezzi, MD, Sergio Cortelazzo, MD, Giacomo Gianfaldoni, MD, Alberto Bosi, MD, Brunangelo Falini, MD PhD, Tamara Intermesoli, MD, Chiara Pavoni, Statistician, Renato Bassan, MD, Orietta Spinelli, PhD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1443.
https://doi.org/10.1182/blood-2019-124497
Published: 2019
Journal Articles

Durable Responses Observed in Elderly AML Patients Unfit for Intensive Chemotherapy with First-in Class Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with LDAC: Phase II Open-Label Study

Sonja Loges, MD, PhD, Michael Heuser, MD, Jörg Chromik, MD, Carlos Enrique Vigil, MD, Peter Paschka, MD, Francesca Re, Nicola Di Renzo, MD, Roberto Massimo Lemoli, MD, Daniele Giovanni Mattei, MD, Isabel Ben Batalla, PhD, Monica Hellesoy, PhD, David Micklem, PhD, Robert J. Holt, PhD, James B. Lorens, PhD, Muhammad Shoaib, MD, Hassan Aly, MD PhD, Wouter Hanekom, MD, Walter Fiedler, MD, Jorge E. Cortes, MD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3943.
https://doi.org/10.1182/blood-2019-128683
Published: 2019
Journal Articles

Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06

Chiara Caprioli, MD, Tamara Intermesoli, MD, Orietta Spinelli, PhD, Silvia Salmoiraghi, MSc, Pamela Zanghì, MSc, Roberta Cavagna, MSc, Anna Michelato, PhD, Ksenija Buklijas, MSc, Federica Delaini, MSc, Elena Oldani, MSc, Giacomo Gianfaldoni, MD, Dario Ferrero, MD, Elisabetta Terruzzi, MD, Lorella De Paoli, MD, Chiara Cattaneo, MD, Erika Borlenghi, MD, Irene Cavattoni, MD, Monica Tajana, MD, Anna Maria Scattolin, MD, Daniele Giovanni Mattei, MD, Paolo Corradini, MD, Leonardo Campiotti, MD, Fabio Ciceri, MD, Massimo Bernardi, MD, Elisabetta Todisco, MD, Agostino Cortelezzi, MD, Sergio Cortelazzo, MD, Ernesta Audisio, MD, Filippo Marmont, MD, Alberto Bosi, MD, Brunangelo Falini, MD PhD, Chiara Pavoni, Statistician, Renato Bassan, MD, Alessandro Rambaldi, MD, Federico Lussana, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 434.
https://doi.org/10.1182/blood-2018-99-113869
Published: 2018